Zobrazeno 1 - 10
of 1 632
pro vyhledávání: '"Richetta A"'
Autor:
Argenziano G, Amerio P, Aragone MG, Baggini G, Baldari M, Castelli G, Coppola S, Costanzo A, De Pasquale R, Fargnoli MC, Foti C, Giofrè C, Lembo S, Leporati C, Loconsole F, Malara G, Peris K, Richetta AG, Savoia P, Tiberio R, Travaglini M, Uzzauto MT, Bianchi L
Publikováno v:
Patient Preference and Adherence, Vol Volume 15, Pp 2551-2562 (2021)
Giuseppe Argenziano,1,* Paolo Amerio,2 Maria Grazia Aragone,3 Ginevra Baggini,4 Manuela Baldari,5 Gianpiero Castelli,6 Simmaco Coppola,7 Antonio Costanzo,8,9 Rocco De Pasquale,10 Maria Concetta Fargnoli,11 Caterina Foti,12 Claudia Giofrè,13 Serena L
Externí odkaz:
https://doaj.org/article/c4a24d587ebb4a109ffacd9b7187f80d
Autor:
Nicoletta Bernardini, Annunziata Dattola, Giacomo Caldarola, Diego Orsini, Chiara Assorgi, Alessandra D’Amore, Giulia Maretti, Antonio Giovanni Richetta, Ersilia Tolino, Nevena Skroza, Concetta Potenza
Publikováno v:
Drugs in Context, Vol 13, Pp 1-6 (2024)
Psoriasis is a chronic inflammatory disease that can affect any part of the body but, when it appears in certain areas, like the face, it can have a very significant psychological impact. Biologics, in particular IL-17 and IL-23 drug inhibitors, have
Externí odkaz:
https://doaj.org/article/d24f93036ce34a7ab8c5f3805c270115
Autor:
Annunziata Dattola, Nicoletta Bernardini, Francesca Svara, Anna Balato, Giacomo Caldarola, Domenico D’Amico, Clara De Simone, Eugenia Veronica Di Brizzi, Maria Esposito, Claudia Giofrè, Domenico Giordano, Claudio Guarneri, Francesco Loconsole, Viviana Lora, Gaia Moretta, Diego Orsini, Severino Persechino, Concetta Potenza, Simone Ragonesi, Giovanni Pellacani, Ketty Peris, Maria Concetta Fargnoli, Antonio Giovanni Richetta
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Introduction: Psoriasis is a chronic immune-mediated disease that can be challenging to treat, especially in patients with severe disease or high body weight. Tildrakizumab is a monoclonal antibody which inhibits IL-23, approved for moderate-to-sever
Externí odkaz:
https://doaj.org/article/0025053498fe49b2841bd41e99bc2742
Autor:
D. Orsini, M. Megna, C. Assorgi, A. Balato, R. Balestri, N. Bernardini, A. Bettacchi, T. Bianchelli, L. Bianchi, G. Buggiani, M. Burlando, AMG. Brunasso, G. Caldarola, N. Cameli, A. Campanati, E. Campione, A. Carugno, K. Chersi, A. Conti, A. Costanzo, E. Cozzani, A. Cuccia, D. D’Amico, G. Dal Bello, E. G. Dall’Olio, P. Dapavo, C. De Simone, E. V. Di Brizzi, A. Di Cesare, V. Dini, M. Esposito, E. Errichetti, M. C. Fargnoli, C. S. Fiorella, A. Foti, Z. Fratton, F. M. Gaiani, P. Gisondi, R. Giuffrida, A. Giunta, C. Guarneri, A. Legori, F. Loconsole, P. Malagoli, A. Narcisi, M. Paolinelli, L. Potestio, F. Prignano, G. Rech, A. Rossi, N. Skroza, F. Trovato, M. Venturini, A. G. Richetta, G. Pellacani, A. Dattola
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Purpose of the article: The aim of this multicenter observational study is to report data from real world on the use of bimekizumab in patients aged ≥ 65 years with moderate-to-severe plaque psoriasis. Elderly patients are poorly represented in cli
Externí odkaz:
https://doaj.org/article/7ef04e4cae9b4655894c0414dffd2eb3
Autor:
Diego Orsini, Giacomo Caldarola, Annunziata Dattola, Elena Campione, Nicoletta Bernardini, Pasquale Frascione, Clara De Simone, Antonio G. Richetta, Marco Galluzzo, Nevena Skroza, Chiara Assorgi, Emanuele Amore, Gennaro M. Falco, Ruslana Gaeta Shumak, Fabio Artosi, Giulia Maretti, Concetta Potenza, Luca Bianchi, Giovanni Pellacani, Ketty Peris, Claudio Bonifati, Dario Graceffa
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Purpose of the article: Interleukin-23 inhibitors, such as tildrakizumab, have emerged as safe and effective options for the management of psoriasis. Yet their efficacy in elderly patients (aged 65 years or more), particularly in those with difficult
Externí odkaz:
https://doaj.org/article/6ed0bed7541c4a9084145e7ddf8bf2a1
Autor:
Annunziata Dattola, Martina Tolone, Emanuele Amore, Luigi Bennardo, Simone Amato, Teresa Grieco, Antonio Giovanni Richetta, Giovanni Pellacani, Nevena Skroza, Steven Paul Nisticò
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss 3 (2024)
Introduction: The advent of biotechnological drugs has significantly changed the management of atopic dermatitis (AD) and the approach to the moderate-to-severe form of this chronic relapsing disease. Objectives: The aim of our review is to summari
Externí odkaz:
https://doaj.org/article/ca7ce1e99b07470987c1f55e9810114c
Autor:
Annunziata Dattola, Nicoletta Bernardini, Giacomo Caldarola, Rosa Coppola, Clara De Simone, Domenico Giordano, Alessandro Giunta, Gaia Moretta, Gianluca Pagnanelli, Vincenzo Panasiti, Severino Persechino, Concetta Potenza, Federica Trovato, Arianna Zangrilli, Luca Bianchi, Giovanni Pellacani, Ketty Peris, Antonio Giovanni Richetta
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss 3 (2024)
Introduction: This was an observational, retrospective, multicenter study, enrolling elderly patients (>65 years old) treated with ixekizumab with a diagnosis of psoriasis (PsO) and/or psoriatic arthritis (PsA) during the period 2020 to 2023. Objecti
Externí odkaz:
https://doaj.org/article/a05b21fd116641508cf30fcf6a57ea32
Autor:
Elena Campione, Fabio Artosi, Ruslana Gaeta Shumak, Alessandro Giunta, Giuseppe Argenziano, Chiara Assorgi, Anna Balato, Nicoletta Bernardini, Alexandra Maria Giovanna Brunasso, Martina Burlando, Giacomo Caldarola, Anna Campanati, Andrea Carugno, Franco Castelli, Andrea Conti, Antonio Costanzo, Aldo Cuccia, Paolo Dapavo, Annunziata Dattola, Clara De Simone, Vito Di Lernia, Valentina Dini, Massimo Donini, Enzo Errichetti, Maria Esposito, Maria Concetta Fargnoli, Antonio Foti, Carmen Fiorella, Luigi Gargiulo, Paolo Gisondi, Claudio Guarneri, Agostina Legori, Serena Lembo, Francesco Loconsole, Piergiorigio Malagoli, Angelo Valerio Marzano, Santo Raffaele Mercuri, Matteo Megna, Giuseppe Micali, Edoardo Mortato, Maria Letizia Musumeci, Alessandra Narcisi, Anna Maria Offidani, Diego Orsini, Giovanni Paolino, Giovanni Pellacani, Ketty Peris, Concetta Potenza, Francesca Prignano, Pietro Quaglino, Simone Ribero, Antonio Giovanni Richetta, Marco Romanelli, Antonio Rossi, Davide Strippoli, Emanuele Trovato, Marina Venturini, Luca Bianchi
Publikováno v:
Pharmaceuticals, Vol 17, Iss 10, p 1378 (2024)
(1) Background/Objectives: Nail psoriasis (NP) is a chronic and difficult-to-treat disease, which causes significant social stigma and impairs the patients’ quality of life. Moreover, nail psoriasis is a true therapeutic challenge for clinicians. T
Externí odkaz:
https://doaj.org/article/de7ced820b9f497b8c4d8350be2e627f
Autor:
Diego Orsini, Piergiorgio Malagoli, Anna Balato, Luca Bianchi, Pina Brianti, Dario Buononato, Martina Burlando, Giacomo Caldarola, Anna Campanati, Elena Campione, Carlo G. Carrera, Andrea Carugno, Francesco Cusano, Paolo Dapavo, Annunziata Dattola, Clara De Simone, Valentina Dini, Maria Esposito, Maria C. Fargnoli, Francesca M. Gaiani, Luigi Gargiulo, Paolo Gisondi, Alessandro Giunta, Luciano Ibba, Claudia Lasagni, Francesco Loconsole, Vincenzo Maione, Edoardo Mortato, Angelo V. Marzano, Martina Maurelli, Matteo Megna, Santo R. Mercuri, Alessandra Narcisi, Annamaria Offidani, Giovanni Paolino, Aurora Parodi, Giovanni Pellacani, Luca Potestio, Pietro Quaglino, Antonio G. Richetta, Francesca Romano, Paolo Sena, Marina Venturini, Chiara Assorgi, Antonio Costanzo
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss 2 (2024)
Introduction: Genital involvement is observed in approximately 60% of patients with psoriasis, presenting clinicians with formidable challenges in treatment. While new biologic drugs have emerged as safe and effective options for managing psoriasis,
Externí odkaz:
https://doaj.org/article/59fd209fd8eb441cabd179657001da3a
Autor:
Carla Richetta, Yevgeny Karepov
Publikováno v:
Neurotrauma Reports, Vol 4, Iss 1, Pp 797-804 (2023)
E-bikes (electrical bicycles and scooters) have been increasingly used as a means of transportation, especially among young adults. E-bikers have more accidents, at higher velocities and more severe kinematics, increasing the rate of neurosurgical in
Externí odkaz:
https://doaj.org/article/f32a93c8ba8e4c60a3c4b5e19d47831a